• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中年男性高血压。长期高血压护理中的管理、发病率及预后因素。

Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.

作者信息

Samuelsson O

出版信息

Acta Med Scand Suppl. 1985;702:1-79.

PMID:3866485
Abstract

The effects of long-term (10 years) management at a special out-patient hypertension clinic with respect to dropout rate, side effects, blood pressure (BP) control, target organ involvement, prognostic factors and cardiovascular morbidity have been studied in 686 middle-aged male hypertensives. The impact of antihypertensive treatment, as one ingredient of multiple risk factor intervention, on mortality and morbidity in an urban, male population have been analysed. The hypertensive patients were derived from a random sample of men, aged 47-54 years at entry, constituting the intervention group (n = 7,455) of a multifactorial primary prevention trail. The whole population sample was studied regarding the effect of treatment on morbidity. The 10-year drop-out rate (declined follow-up/unknown reasons) was low (5%) being highest during the first year. The frequency of severe adverse drug effects was low (3% per year) after the initial period when treatment was started. An acceptable BP reduction was achieved in the majority of patients, but in many cases first after a few years' treatment and requiring combination drug therapy. Two-thirds of the patients achieved the goal BP (i.e. less than 160/95 mm Hg). These results are attributed to the organisation of the clinic and emphasise the need for frequent check-ups during the early phase of treatment and an easy accessibility to nurses and physicians. Except for a significant regression of ST- and T-wave changes on the conventional ECG during the first treatment year signs of heart (conventional ECG, chest X-ray) and kidney (albuminuria, serum creatinine) involvement remained unchanged or increased slightly during follow-up. Angina pectoris (AP), intermittent claudication (IC) and congestive heart failure (CHF) were common complications. The prevalence increased steadily with an average annual incidence of 1.3% (AP), 0.6% (IC) and 0.6% (CHF). ECG signs indicating subclinical heart disease were risk factor for AP and CHF. Smoking was an independent risk factor for any one of these cardiovascular disorders. The 10-year incidence of total mortality was 11.1%, and of CHD and stroke morbidity 12.2% and 4.1%, respectively. Independent risk factors (entry variables) for CHD were diastolic BP, smoking, serum cholesterol, AP and proteinuria. A previous stroke, smoking and proteinuria were independently associated with stroke morbidity. Hence, the risk factor pattern was similar to that known to operate in the general population.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在一家高血压专科门诊对686名中年男性高血压患者进行了为期10年的管理研究,内容涉及失访率、副作用、血压控制、靶器官受累情况、预后因素及心血管疾病发病率。分析了作为多危险因素干预一部分的降压治疗对城市男性人群死亡率和发病率的影响。这些高血压患者来自一个随机抽样的男性群体,入组时年龄为47 - 54岁,构成一项多因素一级预防试验的干预组(n = 7455)。对整个人口样本研究了治疗对发病率的影响。10年失访率(因随访中断/不明原因)较低(5%),第一年最高。开始治疗后的初始阶段过后,严重药物不良反应的发生率较低(每年3%)。大多数患者实现了可接受的血压降低,但在许多情况下,是在数年治疗后才实现,且需要联合药物治疗。三分之二的患者达到了目标血压(即低于160/95 mmHg)。这些结果归因于诊所的组织架构,并强调在治疗早期需要频繁检查,以及方便患者接触护士和医生。除了在治疗的第一年常规心电图上ST段和T波改变有显著消退外,心脏(常规心电图、胸部X线)和肾脏(蛋白尿、血清肌酐)受累的体征在随访期间保持不变或略有增加。心绞痛(AP)、间歇性跛行(IC)和充血性心力衰竭(CHF)是常见并发症。患病率稳步上升,平均年发病率分别为1.3%(AP)、0.6%(IC)和0.6%(CHF)。提示亚临床心脏病的心电图体征是AP和CHF的危险因素。吸烟是这些心血管疾病中任何一种的独立危险因素。10年总死亡率为11.1%,冠心病和中风发病率分别为12.2%和4.1%。冠心病的独立危险因素(入组变量)为舒张压、吸烟、血清胆固醇、AP和蛋白尿。既往中风、吸烟和蛋白尿与中风发病率独立相关。因此,危险因素模式与一般人群中已知的模式相似。(摘要截选至400字)

相似文献

1
Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.中年男性高血压。长期高血压护理中的管理、发病率及预后因素。
Acta Med Scand Suppl. 1985;702:1-79.
2
Angina pectoris, intermittent claudication and congestive heart failure in middle-aged male hypertensives. Development and predictive factors during long-term antihypertensive care. The Primary Preventive Trial, Göteborg, Sweden.中年男性高血压患者的心绞痛、间歇性跛行和充血性心力衰竭。长期抗高血压治疗期间的发生情况及预测因素。瑞典哥德堡初级预防试验。
Acta Med Scand. 1987;221(1):23-32.
3
Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.经治疗的高血压患者中的中风和冠心病——一项长达三十年的前瞻性队列研究
J Intern Med. 2005 Jun;257(6):496-502. doi: 10.1111/j.1365-2796.2005.01497.x.
4
Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.原发性高血压的长期肾功能:一项流行病学和病理生理学研究。
Scand J Urol Nephrol Suppl. 1999;199:1-36.
5
Prognostic factors in treated hypertension.经治疗高血压的预后因素。
J Hypertens Suppl. 1985 Dec;3(3):S497-500.
6
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).抗高血压治疗期间心电图应变模式变化的预后价值:氯沙坦干预降低高血压终点事件研究(LIFE)
Circulation. 2009 Apr 14;119(14):1883-91. doi: 10.1161/CIRCULATIONAHA.108.812313. Epub 2009 Mar 30.
7
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
8
Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.血压水平、危险因素与抗高血压治疗:来自SHEAF研究的经验教训。
J Hum Hypertens. 2001 Dec;15(12):841-8. doi: 10.1038/sj.jhh.1001280.
9
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
10
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.

引用本文的文献

1
Does cardiovascular protection translate into renal protection?心血管保护是否能转化为肾脏保护?
Nat Rev Cardiol. 2014 Dec;11(12):742-6. doi: 10.1038/nrcardio.2014.97. Epub 2014 Jul 8.
2
Markers of loss of control of hypertension.高血压控制不佳的标志物。
Can Fam Physician. 2003 Oct;49:1323-31.
3
Proteinuria: an underappreciated risk factor in cardiovascular disease.蛋白尿:心血管疾病中一个未被充分认识的危险因素。
Curr Cardiol Rep. 2002 Nov;4(6):458-62. doi: 10.1007/s11886-002-0106-5.
4
How relevant and frequent is the presence of mild renal insufficiency in essential hypertension?轻度肾功能不全在原发性高血压中的相关性及发生率如何?
J Clin Hypertens (Greenwich). 2002 Sep-Oct;4(5):332-6. doi: 10.1111/j.1524-6175.2002.01003.x.
5
Renal protection by antihypertensive therapy.抗高血压治疗的肾脏保护作用。
Curr Hypertens Rep. 2002 Aug;4(4):324-8. doi: 10.1007/s11906-996-0012-0.
6
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.治疗高脂血症或高血压对降低冠状动脉疾病死亡风险的影响。
CMAJ. 1999 May 18;160(10):1449-55.
7
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.治疗的高血压患者的糖尿病和血清甘油三酯浓度升高——它们具有预后重要性吗?观察性研究。
BMJ. 1996 Sep 14;313(7058):660-3. doi: 10.1136/bmj.313.7058.660.
8
Hypertension in the elderly: age- and disease-related complications and therapeutic implications.老年高血压:与年龄和疾病相关的并发症及治疗意义
Cardiovasc Drugs Ther. 1993 Aug;7(4):643-53. doi: 10.1007/BF00877817.
9
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.血压控制与首次急性心肌梗死风险:斯卡罗堡高血压项目
BMJ. 1994 Mar 12;308(6930):681-6. doi: 10.1136/bmj.308.6930.681.
10
Rationale for combination therapy.联合治疗的基本原理。
Br J Clin Pharmacol. 1987;23 Suppl 1(Suppl 1):15S-19S. doi: 10.1111/j.1365-2125.1987.tb03118.x.